L471-2540 Screening compound: 1-(2,4-dimethyl-1,3-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carbonyl}piperazine

L471-2540 Screening compound: 1-(2,4-dimethyl-1,3-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carbonyl}piperazine
L471-2540 Screening compound: 1-(2,4-dimethyl-1,3-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carbonyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L471-2540
1-(2,4-dimethyl-1,3-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carbonyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L471-2540

Molecular Formula

C25H30N6O3S (C25 H30 N6 O3 S)

Compound Name

1-(2,4-dimethyl-1,3-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carbonyl}piperazine

IUPAC name

1-(24-dimethyl-13-thiazole-5-carbonyl)-4-{3-[4-(4-methylpiperidin-1-yl)phenyl]-124-oxadiazole-5-carbonyl}piperazine

SMILES

CC(CC1)CCN1c(cc1)ccc1-c1noc(C(N(CC2)CCN2C(c2c(C)nc(C)s2)=O)=O)n1

InChI

InChI=1S/C25H30N6O3S/c1-16-8-10-29(11-9-16)20-6-4-19(5-7-20)22-27-23(34-28-22)25(33)31-14-12-30(13-15-31)24(32)21-17(2)26-18(3)35-21/h4-7,16H,8-15H2,1-3H3

InChI Key

VXNNHVNLQHMVLP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27454846

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.868

Distribution Coefficient, logD

3.868

Water Solubility, LogSw

-3.92

Polar Surface Area

78.861

Acid Dissociation Constant (pKa)

25.52

Base Dissociation Constant (pKb)

3.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

L471-2540 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with L471-2540 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L471-2540?
Check Price and Availability of L471-2540, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L471-2540 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L471-2540
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L471-2540
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L471-2540 available by request